Dr. Saud A. Sadiq Editorial Review of Stem Cells in ALS Featured in Neurology®

Thursday, November 21, 2019

Stem cells in amyotrophic lateral sclerosis

Hype or hope?

Saud A. Sadiq, MD, and Christen Shoesmith, MD, FRCPC

Neurology® 2019;93:1-2. doi:10.1212/WNL.0000000000008613

 

Considered an expert in regenerative medicine, Tisch MS Research Center of New York's Director and Chief Research Scientist Dr. Saud A. Sadiq was invited to review the use of stem cells in amyotrophic lateral sclerosis (ALS).

Research performed at Massachusetts General Hospital Neurological Clinical Research Institute (NCRI) under the direction of James Berry, MD et al.

 

TO READ FULL REVIEW PLEASE EMAIL A REQUEST TO: plevin@tischms.org

News Archive

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.